IS REFLEX MLH1 PROMOTER HYPERMETHYLATION TESTING FOLLOWING MLH1 LOSS BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL CARCINOMA BEST PRACTICE?

被引：0
|
作者：
Plotkin, Anna [1 ]
Olkhov-Mitsel, Ekaterina [1 ]
Nofech-Mozes, Sharon [1 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Lab Med & Mol Diagnost, Toronto, ON, Canada
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷
关键词：
D O I：
10.1136/ijgc-2022-igcs.49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5/#274
引用
收藏
页码：A26 / A27
页数：2
相关论文
共 50 条
  • [1] Utility of MLH1 Hypermethylation Analysis in MLH1 Deficient Endometrial Carcinomas: Is It Best Practice?
    Plotkin, Anna
    Olkhov-Mitsel, Ekaterina
    Nofech-Mozes, Sharon
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S1739 - S1740
  • [2] MLH1 promoter hypermethylation in endometrial carcinoma.
    Honore, LH
    Otto, C
    Helmle, K
    Whiteside, D
    Andrew, SE
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 258 - 258
  • [3] Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
    Bosch, Dustin E.
    Yeh, Matthew M.
    Salipante, Stephen J.
    Jacobson, Angela
    Cohen, Stacey A.
    Konnick, Eric Q.
    Paulson, Vera A.
    [J]. JCO PRECISION ONCOLOGY, 2022, 6
  • [4] Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
    Takanori Yokoyama
    Kazuhiro Takehara
    Nao Sugimoto
    Keika Kaneko
    Etsuko Fujimoto
    Mika Okazawa-Sakai
    Shinichi Okame
    Yuko Shiroyama
    Takashi Yokoyama
    Norihiro Teramoto
    Shozo Ohsumi
    Shinya Saito
    Kazuho Imai
    Kokichi Sugano
    [J]. BMC Cancer, 18
  • [5] Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
    Yokoyama, Takanori
    Takehara, Kazuhiro
    Sugimoto, Nao
    Kaneko, Keika
    Fujimoto, Etsuko
    Okazawa-Sakai, Mika
    Okame, Shinichi
    Shiroyama, Yuko
    Yokoyama, Takashi
    Teramoto, Norihiro
    Ohsumi, Shozo
    Saito, Shinya
    Imai, Kazuho
    Sugano, Kokichi
    [J]. BMC CANCER, 2018, 18
  • [6] Speckled MLH1 Staining Pattern by Immunohistochemistry in Endometrial Carcinoma
    Cagaanan, Alain
    Karasiewicz, Kristen
    Weisman, Paul
    McGregor, Stephanie
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1021 - 1022
  • [7] Speckled MLH1 Staining Pattern by Immunohistochemistry in Endometrial Carcinoma
    Cagaanan, Alain
    Karasiewicz, Kristen
    Weisman, Paul
    McGregor, Stephanie
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1021 - 1022
  • [8] MLH1 promoter hypermethylation in endometrial carcinomas with microsatellite instability and endometrial hyperplasias.
    Esteller, M
    Catasus, L
    Lagarda, E
    Machin, P
    Herman, JH
    Matias-Guiu, X
    Prat, J
    [J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 116A - 116A
  • [9] Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers
    Kanaya, T
    Kyo, S
    Maida, Y
    Yatabe, N
    Tanaka, M
    Nakamura, M
    Inoue, M
    [J]. ONCOGENE, 2003, 22 (15) : 2352 - 2360
  • [10] Punctate Pattern Nuclear MLH1 Immunoexpression Without Classic Nuclear MLH1 Staining is an Artifact in MMR Deficient Endometrial Cancer that Merits MLH1 Promoter Methylation Testing
    Bhardwaj, Swati
    Rabban, Joseph
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S861 - S861
12345